Community-based cross-sectional study: The association of lipids with hepatitis C seropositivity and diabetes mellitus

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 11, 2012, Pages 1688-1694

  Liu, Ju Ling ^a   Chen, Jing Yi ^b   Chen, Chao Tung ^c   Wang, Jing Houng ^c   Lin, Chih Yun ^c   Chen, Pao Fei ^c   Hung, Chao Hung ^c   Kee, Kwong Ming ^c   Lee, Chuan Mo ^c   Tsai, Lin San ^d   Chen, Shu Chuan ^d   Lin, Sheng Che ^d   Lu, Sheng Nan ^c  

^a TAJEN UNIVERSITY   (Taiwan)

^b St Joseph Hospital   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d DEPARTMENT OF HEALTH   (Taiwan)

Author keywords

Cholesterol; Hepatitis C; Hyperlipidemia; Triglyceride; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; HEPATITIS B SURFACE ANTIGEN; TRIACYLGLYCEROL;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMMUNITY ASSESSMENT; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SCREENING; SEROLOGY; TAIWAN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CHOLESTEROL; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SURVEYS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; TAIWAN; TRIGLYCERIDES;

EID: 84868135971     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07212.x     Document Type: Article

References (46)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
2. Lauer GM, Walker BD. Hepatitis C virus infection. N. Engl. J. Med. 2001; 345: 41-52.
3. Anonymous. NIH consensus statement on management of hepatitis C: 2002. NIH Consens. State Sci. Statements 2002; 19: 1-46.
4. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 2000; 20: 1-16.
5. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J. Formos. Med. Assoc. 2007; 106: 148-55.
6. Wang CS, Chang TT, Yao WJ, Chou P. Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. Am. J. Trop. Med. Hyg. 2002; 66: 389-93.
7. Tsai MC, Kee KM, Chen YD etal. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. J. Gastroenterol. Hepatol. 2007; 22: 92-8.
8. World Health Organization of US. Media Centre. Fact sheets. Cited N312 Aug 2011. Available from URL: http://www.who.int/mediacentre/factsheets/fs312/en/index.html
9. Department of Health, Executive Yuan, R.O.C. (Taiwan). Statistics & Publications. Cause of Death Statistics. Cited 30 Jan 2010. Available from URL: http://www.doh.gov.tw/cht2006/index_populace.aspx
10. Dai CY, Chuang WL, Ho CK etal. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J. Hepatol. 2008; 49: 9-16.
11. Siagris D, Christofidou M, Theocharis GJ etal. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J. Viral Hepat. 2006; 13: 56-61.
12. Antonelli A, Ferri C, Fallahi P etal. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology 2004; 43: 238-40.
13. Antonelli A, Ferri C, Fallahi P etal. Hepatitis C virus infection evidence for an association with type 2 diabetes. Diabetes Care 2005; 28: 2548-50.
14. Skowronski M, Zozulinska D, Juszczyk J, Wierusz-Wysocka B. Hepatitis C virus infection: evidence for an association with type 2 diabetes [Letter]. Diabetes Care 2006; 29: 750.
15. Petit JM, Bour JB, Galland-Jos C etal. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J. Hepatol. 2001; 35: 279-83.
16. Mason AL, Lau JY, Hoang N etal. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.
17. Caronia S, Taylor K, Pagliaro L etal. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
18. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J. Hepatol. 2000; 32: 209-17.
19. Huang JF, Dai CY, Hwang SJ etal. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am. J. Gastroenterol. 2007; 102: 1237-43.
20. Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am. J. Epidemiol. 2003; 158: 1154-60.
21. Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am. J. Epidemiol. 2007; 166: 196-203.
22. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19: 998-1000.
23. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J. Hepatol. 2008; 49: 831-44.
24. Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res. Clin. Pract. 2007; 75: 320-6.
25. Poussier A, Lebouvier M, Penfornis A etal. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection. Diabet. Med. 2008; 25: 1237-40.
26. Lu SN, Wang JH, Liu SL etal. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 2006; 107: 2212-22.
27. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J. Hepatol. 1994; 21: 1135-9.
28. Shintani Y, Fujie H, Miyoshi H etal. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8.
29. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann. Intern. Med. 2000; 133: 592-9.
30. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994; 19: 616-27.
31. Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J. Hepatol. 2004; 41: 132-8.
32. Romero-Gomez M, Del Mar Viloria M, Andrade RJ etal. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128: 636-41.
33. Simo R, Lecube A, Genesca J, Esteban JI. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care 2006; 29: 2462-6.
34. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-72.
35. Chen CL, Yang HI, Yang WS etal. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-21.
36. Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment. Pharmacol. Ther. 2006; 23: 1055-65.
37. Akbar DH, Siddique AM, Ahmed MM. Prevalence of Type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia. Med. Princ. Pract. 2002; 11: 82-5.
38. Hourigan LF, Macdonald GA, Purdie D etal. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-19.
39. Zavaroni I, Bonini L, Fantuzzi M, Dall'Aglio E, Passeri M, Reaven GM. Hyperinsulinaemia, obesity, and syndrome X. J. Intern. Med. 1994; 235: 51-6.
40. Mitsuyoshi H, Itoh Y, Sumida Y etal. Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C. Hepatol. Res. 2008; 38: 348-53.
41. Vidali M, Tripodi MF, Ivaldi A etal. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J. Hepatol. 2008; 48: 399-406.
42. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925-9.
43. Antonelli A, Ferri C, Ferrari SM, Colaci M, Sansonno D, Fallahi P. Endocrine manifestations of hepatitis C virus infection. Nat. Clin. Pract. Endocrinol. Metab. 2009; 5: 26-34.
44. Gale EA. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 2005; 48: 2195-9.
45. Antonelli A, Ferri C, Fallahi P etal. Hepatitis C virus infection evidence for an association with type 2 diabetes [Letter]. Diabetes Care 2006; 29: 751.
46. Antonelli A, Tuomi T, Nanniperi M etal. Autoimmune to CD38 and GAD in type I and type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 2002; 45: 1298-306.